Company Profile

Aidar Health Inc
Profile last edited on: 12/26/2023      CAGE: 7RWW7      UEI: JEMYBJLDN1T3

Business Identifier: Develop and deliver innovative digital medicine solutions
Year Founded
2016
First Award
2022
Latest Award
2023
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

8920 State Route 108 Suite B
Columbia, MD 21045
   (443) 875-6456
   contact@aidar.com
   www.aidar.com
Location: Single
Congr. District: 03
County: Howard

Public Profile

Aidar Health, Inc., is a healthcare technology and digital medicine company reimagining today’s standards for clinical trials, chronic care management, and health monitoring. Our rapid medical assessment device, MouthLab, is a non-invasive, hand-held, home monitoring device that measures more than 10 vital medical parameters in 30 seconds. Sensor data is sent in real-time using LTE-M or Bluetooth to our secure HIPAA-compliant cloud, where our proprietary analytics system uses AI and machine learning algorithms to analyze, and generate actionable insights. This data can then be accessed through a physician portal, which allows for timely intervention and treatment modification in order to prevent hospitalization in chronic disease patients.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2023 2 NSF $1,100,000
Project Title: Development of a Smart Remote Health Management System for Patients with Kidney Disease

Key People / Management

  Sathya Elumalai -- Founder & CEO

  Gene Fridman -- CTO & Co-founder

Company News

There are no news available.